Aurinia Pharmaceuticals Inc (AUPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AUPH.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
AUPH Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- AUPH has a lower percent of analysts bearish on the stock than almost 100% of all US stocks.
- Aurinia Pharmaceuticals Inc's percentage of analysts bullish on the stock is higher than 93.78% of stocks in the mid market cap category.
- Aurinia Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 88.7% of stocks in the mid market cap category.
- AUPH has a less variance in analysts' estimates than 23.39% of all US stocks.
- Aurinia Pharmaceuticals Inc's number of analysts covering the stock is greater than 68.27% of Pharmaceutical Products stocks.
- Aurinia Pharmaceuticals Inc's average analyst price target is greater than 39.44% of stocks in the mid market cap category.
- AUPH has a less change in bullishness amongst analysts than almost 100% of all US stocks.
In the Pharmaceutical Products industry, KURA, BCYC and AVDL are the three stocks most similar to Aurinia Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for AUPH? Use POWR Ratings for clearer insight into price direction.